MyoGene Bio - Crunchbase Company Profile & Funding

Q: Who invested in MyoGene Bio?

MyoGene Bio has 4 investors including Parent Project Muscular Dystrophy And Duchenne UK.

Q: When was the last funding round for MyoGene Bio?

MyoGene Bio closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has MyoGene Bio raised to date?

MyoGene Bio has raised obfuscated.

Overview

MyoGene Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About MyoGene Bio

CB Rank

95180

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

Founded

obfuscation

Private

Venture - Series Unknown

Los Angeles, California, United States

1-10

www.myogenebio.com

Biotechnology

Genetics

Health Care

Therapeutics

Wellness

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

MyoGene Bio LLC

Operating Status

Active

Company Type

For Profit

About the Company

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

Contact Email

info@myogenebio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

MyoDys45-55

A gene editing therapy designed to restore functional dystrophin protein in Duchenne muscular dystrophy patients by deleting exons 45-55 of the DMD gene, applicable to approximately half of all patients.

Research & Development

MyoGene Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MyoGene Bio	1	obfuscated obfuscation	Parent Project Muscular Dystrophy	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Parent Project Muscular Dystrophy	Yes	Venture Round - MyoGene Bio	Eric Camino
Parent Project Muscular Dystrophy	Yes	Venture Round - MyoGene Bio	Eric Camino
Parent Project Muscular Dystrophy	Yes	Venture Round - MyoGene Bio	Eric Camino
Parent Project Muscular Dystrophy	Yes	Venture Round - MyoGene Bio	Eric Camino
Parent Project Muscular Dystrophy	Yes	Venture Round - MyoGene Bio	Eric Camino